FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Oprah Co. Sued for Multiple Sclerosis Discrimination

(Posted By: Josi Creek)

A woman who worked for Oprah Winfrey's OWN network claims she was subjected to a hostile work environment  because she suffers from Multiple Sclerosis.
Read more »

Labels:


Thursday

 

Investigators Recruiting Globally For Phase II Study Of Oral Multiple Sclerosis Pill

(Posted By: Josi Creek)

Investigators are recruiting 400 people with relapsing-remitting MS for a study evaluating three doses of ACT-128800, an oral compound that affects immune function, versus placebo. The study sponsor is Actelion Pharmaceuticals, Ltd. 
Read more »

Labels:


Monday

 

Novel multiple sclerosis theory (CCSVI) dealt a blow by studies

(Posted By: Josi Creek)

A novel theory about the cause of multiple sclerosis — one that quickly led to millions of dollars in research pledges and an increasingly popular, though unproved, treatment — took a hit Monday from two studies calling the premise into question.



Read more »

Labels: ,


 

Gene Variant May Increase Severity of Multiple Sclerosis

(Posted By: Josi Creek)

 A new study shows a gene variant may increase the severity of multiple sclerosis (MS) symptoms. The research will be published in the August 3, 2010, issue ofNeurology®, the medical journal of the American Academy of Neurology.
Read more »

Labels:


Sunday

 

FDA Approves First Human Trial of Embryonic Stem Cells

(Posted By: Josi Creek)

The U.S. Food and Drug Administration approved the world’s first human clinical trial of a therapy involving embryonic stem cells, the biotechnology company behind the planned trial announced Friday.

Read more »

Labels: ,


 

Multiple Sclerosis To Be Diagnosed Earlier – Study


(Posted By: Josi Creek)

UCI immunological study finds earlier way to diagnose multiple sclerosis (MS).
Assessing for the increasing presence of antibodies that blocks energy production in neurons, UCI immunologists discovered that it can be used also in diagnosing multiple sclerosis at an earlier stage of the disease than the usual diagnostic tools.
Read more »

Labels:



Go to Newer News Go to Older News